NEBILET

This brand name is authorized in Australia, Brazil, Germany, Ecuador, Estonia, Hong Kong, Croatia, Ireland, Lithuania, Malta, Netherlands, Poland, Romania, Singapore, Tunisia, United Kingdom, South Africa

Active ingredients

The drug NEBILET contains one active pharmaceutical ingredient (API):

1 Nebivolol UNII JGS34J7L9I - NEBIVOLOL HYDROCHLORIDE

Nebivolol is a racemate of two enantiomers, SRRR-nebivolol (or d-nebivolol) and RSSS-nebivolol (or l-nebivolol). It is a competitive and selective beta-receptor antagonist and it has mild vasodilating properties due to an interaction with the L-arginine/nitric oxide pathway. Read about Nebivolol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NEBILET Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C07AB12	Nebivolol	C Cardiovascular system → C07 Beta blocking agents → C07A Beta blocking agents → C07AB Beta blocking agents, selective
Discover more medicines within C07AB12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 9311C, 9312D, 9316H
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 504114004115313, 504114008110316, 504116020054503, 504116020054603, 504116020054703
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 07371053, 07371076, 07371082, 10039701, 10172920, 13595816
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 363661212
Country: EE	Ravimiamet	Identifier(s): 1032297, 1072426, 1072437, 1445116, 1445127, 1445138, 1445149, 1445150, 1880210, 1880221, 1880232, 1880243, 1880254, 1880265, 1880276, 1880287
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 139361, 143301, 16158, 162117, 373485
Country: HK	Department of Health Drug Office	Identifier(s): 59922, 65104
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-645496675
Country: IE	Health Products Regulatory Authority	Identifier(s): 35608, 35653, 54373
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1003103, 1005010, 1005395, 1011147, 1011148, 1051639, 1051640, 1051641, 1051643
Country: MT	Medicines Authority	Identifier(s): MA204/00201
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 46353
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100084850
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W04501001, W04501002, W04501003, W04501004, W04501005, W04501006
Country: SG	Health Sciences Authority	Identifier(s): 11728P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 15463013
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/7.1.3/0495